Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-C

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/15 → 04/5/18

Funding

  • Quintiles Incorporated: $65,306.10